Urelumab
id:
urelumab-307-3288942
title:
Urelumab
text:
Urelumab is a fully human, non‐ligand binding, CD137 agonist immunoglobulin‐γ 4 (IgG4) monoclonal antibody. It was developed utilizing Medarex's UltiMAb(R) technology by Bristol-Myers Squibb for the treatment of cancer and solid tumors. Urelumab promotes anti-tumor immunity, or an immune response against tumor cells, via CD137 activation. The application of Urelumab has been limited due to the fact that it can cause severe liver toxicity.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Urelumab
date created:
date modified:
2024-01-31T05:25:32Z
main entity:
{"identifier":"Q7900382","url":"https://www.wikidata.org/entity/Q7900382"}
image:
fields total:
13
integrity:
14